Search is Powered by Google
Cancer / Oncology News

Breast screening in UK - National figures

Main Category: Cancer / Oncology
Article Date: 26 Feb 2004 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

This bulletin summarises information from the computerised call and recall system for breast cancer screening and from breast screening units in England in 2002-03, and includes some information about earlier years.

KEY FACTS

At 31 March 2003:

75.3% of women aged 53-64 resident in England had been screened at least once in the previous 3 years
(75.9% at 31 March 2002).

In 248 of the 304 Primary Care Organisations the coverage was 70% or higher (261 at 31 March 2002); coverage was lower than 60% in 20 Primary Care Organisations (14 at 31 March 2002).

In 2002-03:


75% of women aged 50-64 invited for screening were screened.

1.3 million women of all ages were screened within the programme.

9,849 cases of cancer were diagnosed in women of all ages screened.

Bulletin 2004/06
Published February 2004
Free of charge
ISBN 1 84182 824 6
© Crown Copyright 2004
These National Statistics were prepared by the Government Statistical Service




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...